Ackermann Michael 4
4 · Tarsus Pharmaceuticals, Inc. · Filed May 9, 2022
Insider Transaction Report
Form 4
Ackermann Michael
Director10% Owner
Transactions
- Purchase
Common Stock
2022-05-05$13.50/sh+100,000$1,350,000→ 100,000 total(indirect: By Trust)
Holdings
- 1,204,016
Common Stock
Footnotes (2)
- [F1]The Reporting Person purchased the shares of common stock reported hereby from the underwriters in an underwritten public offering conducted by the Issuer pursuant to an underwriting agreement, dated May 2, 2022, between the Issuer and the representatives of the several underwriters. Each share of common stock was sold by the underwriters at a price of $13.50 per share.
- [F2]The Reporting Person is the trustee of the Ackermann & Elmen-Gruys Trust Dated June 24, 2014 and has voting and dispositive power with respect to these shares.